Farther Finance Advisors’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$290K Hold
4,978
– – ﹤0.01% 2009
2026
Q2
$322K Hold
4,978
– – ﹤0.01% 1893
2026
Q1
$263K Hold
4,978
– – ﹤0.01% 1825
2025
Q4
$255K Hold
4,978
– – ﹤0.01% 1758
2025
Q3
$193K Hold
4,978
– – ﹤0.01% 1627
2025
Q2
$150K Hold
4,978
– – ﹤0.01% 1545
2025
Q1
$134K Hold
4,978
– – ﹤0.01% 1401
2024
Q4
$164K Buy
4,978
+4,850
+3,789% +$183K 0.01% 1073
2024
Q3
$4.78K Hold
128
– – ﹤0.01% 2665
2024
Q2
$4.33K Hold
128
– – ﹤0.01% 2463
2024
Q1
$4.51K Hold
128
– – ﹤0.01% 2116
2023
Q4
$4.22K Hold
128
– – ﹤0.01% 2054
2023
Q3
$3.48K Hold
128
– – ﹤0.01% 1643
2023
Q2
$4.04K Hold
128
– – ﹤0.01% 1502
2023
Q1
$3.48K Hold
128
– – ﹤0.01% 1445
2022
Q4
$3.89K Buy
+128
New +$3.85K ﹤0.01% 1255

Other funds holding SBIO

Farther Finance Advisors's SBIO Position: Q3 2026 in Review

Farther Finance Advisors held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q3 2026 at 4,978 shares worth $290K. The position accounts for ﹤0.01% of the portfolio, ranked #2009.

Farther Finance Advisors first reported a position in SBIO in Q4 2022 and has held it in 16 quarters since. The position peaked at $322K in Q2 2026. 3 funds tracked by Wall St. Rank hold SBIO as of Q3 2026.

  • Farther Finance Advisors held 4,978 shares of ALPS Medical Breakthroughs ETF worth $290K as of Q3 2026.
  • Farther Finance Advisors left its ALPS Medical Breakthroughs ETF share count unchanged in Q3 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2009 holding.
  • Farther Finance Advisors first reported a position in ALPS Medical Breakthroughs ETF in Q4 2022 and has held it in 16 quarters since.
  • Farther Finance Advisors's ALPS Medical Breakthroughs ETF position peaked at $322K in Q2 2026.
  • 3 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.